Data / Form D filings / IGI LABORATORIES, INC
IGI LABORATORIES, INC: Form D filings
IGI LABORATORIES, INC, a pharmaceuticals company in Buena, NJ, filed 5 Form D notices with the SEC between 2009 and 2013. The latest, on January 7, 2013, reports $2 million sold of a $2 million offering to 1 investor.
Find out what IGI LABORATORIES, INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 105 LINCOLN AVENUE, Buena, NJ, 08310
- Phone
- (856) 697-1441
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- $5,000,001 - $25,000,000
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 352998
The full lists. Form D filings in New Jersey: 714 rows, $35.70, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jan 7, 2013 | New notice | $2,000,000 | $2,000,000 | $0 | 1 | Dec 21, 2012 | sec.gov |
| Jan 4, 2011 | New notice | $8,813 | $8,813 | $0 | 1 | Dec 21, 2010 | sec.gov |
| Dec 22, 2010 | New notice | $6,600,000 | $6,500,000 | $100,000 | 78 | Dec 8, 2010 | sec.gov |
| Apr 9, 2010 | New notice | $1,550,000 | $1,550,000 | $0 | 13 | Mar 29, 2010 | sec.gov |
| Apr 14, 2009 | New notice | $6,000,000 | $6,000,000 | $0 | 2 | Mar 13, 2009 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Jason Grenfell-Gardner | Executive Officer | |
| Jenniffer Collins | Executive Officer | |
| Nadya Lawrence | Executive Officer | |
| Joyce Erony | Director | |
| James Gale | Director | |
| Bhaskar Chaudhuri | Director | |
| Narendra Borkar | Director | |
| Michael Hemric | Director |
Other pharmaceuticals companies in New Jersey that filed recently
- Grace Therapeutics, Inc. $10 million · Aug 11, 2026
Every Form D from the week of Jan 7, 2013 · All recent filings in New Jersey · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what IGI LABORATORIES, INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.